159870-95-8 Usage
General Description
2-chlorooxazolo[5,4-b]pyridine is a heterocyclic chemical compound with a structure containing a chloro substituent on the oxazolo ring. It is commonly used as a building block in organic synthesis for the preparation of various pharmaceuticals and agrochemicals. 2-chlorooxazolo[5,4-b]pyridine has also been studied for its potential biological activities, including its antimicrobial, antiviral, and anti-inflammatory properties. The chemical structure of 2-chlorooxazolo[5,4-b]pyridine makes it a valuable intermediate for the development of new drugs and materials with diverse applications. However, it is important to handle this compound with caution as it may pose risks to human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 159870-95-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,8,7 and 0 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 159870-95:
(8*1)+(7*5)+(6*9)+(5*8)+(4*7)+(3*0)+(2*9)+(1*5)=188
188 % 10 = 8
So 159870-95-8 is a valid CAS Registry Number.
159870-95-8Relevant articles and documents
HMOX1 inducers
-
, (2020/09/18)
The present invention is related to compounds of structure (I) as heme oxygenase 1 (HMOX 1) inducers. The present invention is also related a method of controlling the activity or the amount, or both the activity and the amount, of heme-oxygenase 1 in a mammalian subject. The definitions of the variables are provided herein.
Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
-
Page/Page column 81-82, (2010/11/23)
This invention is concerned with compounds of the formula wherein A, B1, B2, R1, R2 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.